NY
Closed
LDN
Closed
TKY
Closed
Your inflation
Subscribe
16 Oct

Topics ›

China

China's economy, trade and technology, and how they reach markets elsewhere. 6 items, newest first.

October 2026

  1. Geopolitics
    China GDP growth: 4.5% in the third quarter, carried by exports as investment falls 7.2%

    China GDP growth picked up to 4.5% in the third quarter. Exports rose 16.4% this year, but investment fell 7.2% and retail sales grew just 1.1%.

    Market noteThe Notebook Desk3 min
  2. Geopolitics
    EU-China hybrid deal: imports capped at 350,000 a year, less than half this year's

    China will hold hybrid car exports to the EU to 350,000 a year from December, against about 800,000 this year. The EU's deficit with China was €372bn in 2025.

    Market noteThe Notebook Desk3 min
  3. Commodities
    China has stopped selling fuel abroad for October, as Europe weighs a diesel release

    Chinese refiners have halted exports of diesel, petrol and jet fuel to rebuild stocks at home. Europe is discussing a 50m-barrel diesel release. Diesel already sells for about $90 a barrel more than crude.

    Market noteThe Notebook Desk3 min
  4. Equities
    DeepSeek and Huawei go after the software that keeps Nvidia on top

    This year's chip rally rests on a few leaders. China is building its own chips, memory and software to replace them. Nvidia barely moved, but a DeepSeek scare cost it $593bn in a day last year.

    Market noteThe Notebook Desk4 min
  5. Geopolitics
    US AI labs are making the case against cheap Chinese models

    OpenAI accused Moonshot of copying its models, and Anthropic warned that a free Chinese model can build working exploits. Both say they oppose a ban. Their rivals sell for far less.

    Market noteThe Notebook Desk4 min

September 2026

  1. Equities
    Novo is buying Chinese obesity drugs, but its record high is a long way off

    Novo Nordisk will pay up to $2.6bn for an early-stage weekly pill from Hengrui. Its shares are down more than 70% from the peak, as Lilly wins in America and generics undercut Novo abroad.

    Market noteThe Notebook Desk3 min

WeeklyThe Notebook by email

The week, in one email

Once a week: the stories we published, and the releases and decisions due in the week ahead. Free. One click stops it.

We email you a link to confirm. By signing up, you agree to the Terms and the Privacy policy.